The pharmacoepidemiological and clinico-economic analysis of consumption of antibacterial drugs in a multi-specialty hospital
DOI:
https://doi.org/10.24959/sphhcj.18.108Keywords:
pharmacoepidemiology, antimicrobials, multi-specialty hospitalAbstract
Information on consumption of antimicrobials in hospitals indirectly reflects implementation of medical care standards, as well as ideas of health professionals about the problems of prevention and treatment of infectious diseases.
Aim. To conduct the comprehensive analysis of the material costs and consumption of antimicrobials for systemic use in a multi-specialty hospital.
Materials and methods. As a result of the studies conducted it was shown that in the hospital for 5 years the approaches to the starting empirical antibacterial therapy of diseases requiring the use of antimicrobial agents were almost completely replaced. In addition, there was transition to the cephalosporin therapy (cefazolin and ceftriaxone) and the loss of interest in antimicrobial drugs of the penicillin group and in drugs from the group of fluoroquinolones and macrolides.
Results. The monitoring of the consumption of antibacterial drugs conducted in the hospital allows us to make strategic decisions in order to optimize the antibiotic therapy and adjust the amount and range of antibiotics used with the profile of the hospital. Complex implementation of ABC-analysis and DDD-analysis allows comparing the priority data of financial costs and the level of consumption of antimicrobials, it allows optimizing the use of antibiotics in a multi-specialty hospital.
Conclusions. The results of the analysis are the ground for redistribution of financial flows in the group of antibacterial agents with improvement of the assortment, they also allow to optimize the use of antibiotics in the hospital units, and based on the data obtained to develop and implement the practice of application of different forms of antibacterial drugs taking into account the principles of evidence-based medicine and the results of infection monitoring.
References
Paravina, Ye. V., Zhestkov, A. V., Kulagin, O. L. (2011). Sovremennaia farmakoekonomika i farmakoepidemiologiia, 4 (1), 61–62.
Yagudina, R. I. (2017). Farmakoekonomika.Moscow: Feniks, 237
Gusarov, V. G., Nesterova, Ye. Ye., Lashenkova, N. N., Petrova, N. V., Silaieva N. A., Tertitskaia, A. B., Teplykh, B. A., Gorokhovatskii, Yu. I., Zamiatin, M. N. (2015). Epidemiologiia i infektsionnyie bolezni, 20 (5), 11–18.
World Health Organization. (2014). Antimicrobial resistance: global report on surveillance.
International Pharmaceuticals Federation. (2008). FIP Statement of policy control of antimicrobial medicines resistance (AMR).The Hague.
Kuznetsov, V. I., Chepurina, N. G., Shmidt, N. V. (2016). Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta, 4 (60), 37–39.
WHO Regional Office for Europe. (2014). Health–2000: Osnovi Evropeiskov politiki v podderzhku deystvii vsego gosudarstva I obshchestva v interesakh zdorovja I blagopoluchija [Health 2020: The foundations of European policy in support of the actions of the entire state and society for health and well–being].Copenhagen.
Belkova, Y. A., Rachina, S. A. (2012). Klinicheskaia farmakologiia i terapiia, 21 (2), 34–41.
Gusarov, V. G., Nesterova, Ye. Ye., Oprishchenko, I.V., Petrova, N. V., Zamiatin, M. N. (2015). Vestnik Natsional’nogo mediko–khirurgicheskogo tsentra im. N.I. Pirogova, 10 (4), 100–103.
Karpov, O. E., Gusarov, V. G., Lashenkova, N. N., Petrova, N. V., Dementiienko, M. V., Shilkin, D. N., Nesterova, Ye. Ye., Zamiatin, M. N. (2016). Obshchaia reanimatologiia, 12 (6), 39–48.
Krasnozhon, T. V., Diachenko, S. V., Adaiev, A. M., Bondarenko, O. A. (2013). Dal’nevostochnyi meditsinskii zhurnal, 3, 118–121.
Paravina, Ye. V., Zhestkov, A. V., Kulagin, O. L. (2010). Izvestiia Samarskogo nauchnogo tsentra Rossiiskoi akademii nauk, 12 (1(7), 1865–1870.
Savchenkova, L. V., Saidova, M. N., Dzhabarov, I.P. (2016). Sovremennaia meditsina: aktual’nye voprosy, 12 (53), 48–55.
About ATC/DDD system.Oslo: World Health Organization Collaborating Center for Drug Statistics Methodology. Available at: http://www. WHOCC.NO/ATCDDD.
Kopylova, I., Kozlov, S., Zharkova, L. (2011). Vrach, 13, 45–49.
Sinopalnikov, A. I., Astafiev, A. V., Styrt, Ye. A. (2012). Klinicheskaia meditsina, 90 (12), 21–26.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
